These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27520989)

  • 21. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial.
    Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Fong B; Wong WK; Tam S; Lau CP; Tse HF
    Eur J Prev Cardiol; 2012 Aug; 19(4):830-9. PubMed ID: 21724681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ivabradine in stable coronary artery disease without clinical heart failure.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
    N Engl J Med; 2014 Sep; 371(12):1091-9. PubMed ID: 25176136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease.
    Warnholtz A; Ostad MA; Heitzer T; Goldmann BU; Nowak G; Munzel T
    Am J Cardiol; 2005 Jan; 95(1):20-3. PubMed ID: 15619388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired nitrate-mediated dilatation could reflect nitrate tolerance in patients with coronary artery disease.
    Hu R; Siu CW; Lau EO; Wang WQ; Lau CP; Tse HF
    Int J Cardiol; 2007 Sep; 120(3):351-6. PubMed ID: 17174421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
    Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure.
    Sallam M; Al-Saadi T; Alshekaili L; Al-Zakwani I
    Curr Vasc Pharmacol; 2016; 14(5):481-486. PubMed ID: 27145825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
    Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.
    Hu S; Belcaro G; Cornelli U; Luzzi R; Cesarone M; Dugall M; Feragalli B; Errichi B; Ippolito E; Grossi M; Hosoi M; Gizzi G; Trignani M
    Int Angiol; 2015 Feb; 34(1):43-52. PubMed ID: 25391252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.
    Hausberg M; Kosch M; Stam F; Heidenreich S; Kisters K; Rahn KH; Barenbrock M
    Kidney Int; 2001 Apr; 59(4):1473-9. PubMed ID: 11260410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
    Celik O; Atasoy MM; Ertürk M; Yalçın AA; Aksu HU; Diker M; Aktürk IF; Atasoy I
    Acta Radiol; 2014 Jul; 55(6):676-81. PubMed ID: 24052362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials.
    Mengesha HG; Weldearegawi B; Petrucka P; Bekele T; Otieno MG; Hailu A
    BMC Cardiovasc Disord; 2017 Apr; 17(1):105. PubMed ID: 28454527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of palmitoylethanolamide on endothelial dysfunction in ocular hypertensive patients: a randomized, placebo-controlled cross-over study.
    Strobbe E; Cellini M; Campos EC
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):968-73. PubMed ID: 23307959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation.
    Patti G; Pasceri V; Melfi R; Goffredo C; Chello M; D'Ambrosio A; Montesanti R; Di Sciascio G
    Circulation; 2005 Jan; 111(1):70-5. PubMed ID: 15630038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between endothelial dysfunction and cardiovascular risk factors and the extent and severity of coronary artery disease.
    Kurtoğlu Gümüşel H; Çatakoğlu AB; Yıldırımtürk Ö; Yurdakul S; Helvacıoğlu F; Ziyrek M; Hanavdeloğulları R; Aytekin V; Aytekin S
    Turk Kardiyol Dern Ars; 2014 Jul; 42(5):435-43. PubMed ID: 25080949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brachial artery diameter and vasodilator response to nitroglycerine, but not flow-mediated dilatation, are associated with the presence and quantity of coronary artery calcium in asymptomatic adults.
    Kullo IJ; Malik AR; Bielak LF; Sheedy PF; Turner ST; Peyser PA
    Clin Sci (Lond); 2007 Feb; 112(3):175-82. PubMed ID: 16987102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.